CAMBRIDGE, U.K., June 27, 2005 (PRIMEZONE) -- Astex Technology Ltd.:
-- Astex announces FDA approval of IND application for novel
cancer drug
-- AT7519 went from first synthesis to IND approval in just 14
months -- twice as fast as industry standard
-- AT7519 has recently received CTA approval
Full press release attached below: http://hugin.info/132636/R/1000129/152841.pdf